Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.
Ontology highlight
ABSTRACT: The dysregulation of gene expression is a critical event involved in all steps of tumorigenesis. Aberrant histone and non-histone acetylation modifications of gene expression due to the abnormal activation of histone deacetylases (HDAC) have been reported in hematologic and solid types of cancer. In this sense, the cancer-associated epigenetic alterations are promising targets for anticancer therapy and chemoprevention. HDAC inhibitors (HDACi) induce histone hyperacetylation within target proteins, altering cell cycle and proliferation, cell differentiation, and the regulation of cell death programs. Over the last three decades, an increasing number of synthetic and naturally derived compounds, such as dietary-derived products, have been demonstrated to act as HDACi and have provided biolo
SUBMITTER: Ruzic D
PROVIDER: S-EPMC8778744 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA